摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzyltriethyl-ammonium hydrogen sulfate | 89039-87-2

中文名称
——
中文别名
——
英文名称
benzyltriethyl-ammonium hydrogen sulfate
英文别名
Benzyl(triethyl)azanium;hydron;sulfate
benzyltriethyl-ammonium hydrogen sulfate化学式
CAS
89039-87-2
化学式
C13H22N*H*O4S
mdl
——
分子量
289.396
InChiKey
MEPLDDAONLVHEF-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.84
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    85.8
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    1-chlorocyclohexyl-phenyl ketonebenzyltriethyl-ammonium hydrogen sulfate氢氧化钾 作用下, 以 为溶剂, 生成 1-Hydroxy-cyclohexyl-phenyl ketone
    参考文献:
    名称:
    Process for producing 1-hydroxy ketones
    摘要:
    该发明涉及一种生产I式化合物的新工艺,其中R1例如为苯基,而R2和R3例如为环己基。应用相转移催化方法,在水的存在下,将式II化合物与羟基离子反应,特别是与碱金属羟基或碱土金属羟基反应。
    公开号:
    US04691058A1
点击查看最新优质反应信息

文献信息

  • ISOSORBIDE-BASED POLYMETHACRYLATES
    申请人:Hillmyer Marc A.
    公开号:US20160229863A1
    公开(公告)日:2016-08-11
    A monomer comprises the structure wherein R 1 comprises H or a substituted hydrocarbyl or unsubstituted hydrocarbyl, and wherein R 2 comprises H, a halide, or a substituted or unsubstituted (C 1 -C 4 ) hydrocarbyl. A method comprises (a) reacting a dianhydrohexitol precursor having the structure with an acyl-group containing compound having the structure wherein R 1 comprises H or a substituted hydrocarbyl or unsubstituted hydrocarbyl, and X comprises a halide, a hydroxyl group, or an acyl group to form an acylated dianhydrohexitol ester intermediate having the structure and (b) reacting the acylated dianhydrohexitol ester intermediate with an acrylic-based compound having the structure wherein R 2 comprises H, a halide, or a substituted or unsubstituted (C 1 -C 4 ) hydrocarbyl, and Y comprises a halide, a hydroxyl group, or an acyl group, to form a dianhydrohexitol-based monomer having the structure
    一个单体包括结构,其中R1包括H或取代的烃基或未取代的烃基,R2包括H,卤素,或取代或未取代的(C1-C4)烃基。一种方法包括(a)将具有结构的二酮六醇前体与具有结构的含酰基化合物反应,其中R1包括H或取代的烃基或未取代的烃基,X包括卤素,羟基,或酰基,形成具有结构的酰化二酮六醇酯中间体,和(b)将酰化二酮六醇酯中间体与具有结构的丙烯基化合物反应,其中R2包括H,卤素,或取代或未取代的(C1-C4)烃基,Y包括卤素,羟基,或酰基,形成具有结构的二酮六醇基单体。
  • MULTISTAGE PROCESS FOR PREPARING ALKALI METAL SALTS OF SPECIFIC 4-HYDROXY-2-OXO-2,5-DIHYDROFURAN-3-CARBOXYLIC ESTERS
    申请人:BAYER CROPSCIENCE AG
    公开号:US20150210662A1
    公开(公告)日:2015-07-30
    The present invention relates to a multi-stage method for preparing alkali metal salts of specific 4-hydroxy-2-oxo-2,5-dihydrofuran-3-carboxylic esters of the formula (I), in which M and R 1 are as defined in the description, which proceeds from malonic ester and does not require isolation of intermediates.
    本发明涉及一种多级方法,用于制备具有特定化学式(I)的4-羟基-2-氧代-2,5-二氢呋喃-3-羧酸酯的碱金属盐,其中M和R1如描述中定义,该方法从丙二酸酯开始,并且不需要分离中间体。
  • PROCESS FOR PRODUCING POLYVALENT GLYCIDYL COMPOUND
    申请人:SHOWA DENKO K.K.
    公开号:US20170342042A1
    公开(公告)日:2017-11-30
    A polyvalent glycidyl compound is produced from a compound having one or more 2-alkenyl ether groups and two or more 2-alkenyl groups using a hydrogen peroxide aqueous solution as an oxidizing agent to oxidize the 2-alkenyl ether groups and the 2-alkenyl groups. A 2-alkenyl ether compound having two or more (un)substituted 2-alkenyl groups and one or more (un)substituted 2-alkenyl ether groups is oxidized using a hydrogen peroxide aqueous solution as an oxidizing agent in the presence of a tungsten compound and a quaternary ammonium salt as catalysts and of phosphoric acid as a co-catalyst, while controlling the pH of the reaction solution to 1.0-4.0 using an acid other than phosphoric acid. During the oxidation, the step of adding the hydrogen peroxide aqueous solution to the reaction solution and the step of adding the acid other than phosphoric acid thereto are alternately repeated at intervals two or more times.
    使用氢氧化物水溶液作为氧化剂,通过氧化2-烯基醚基团和2-烯基基团,从具有一个或多个2-烯基醚基团和两个或多个2-烯基基团的化合物中产生一种多价环氧化物化合物。在钨化合物和季铵盐作为催化剂和磷酸作为协同催化剂的存在下,在使用氢氧化物水溶液作为氧化剂的同时,氧化具有两个或更多个(未)取代的2-烯基基团和一个或多个(未)取代的2-烯基醚基团的2-烯基醚化合物,并使用除磷酸以外的酸将反应液的pH控制在1.0-4.0之间。在氧化过程中,将氢氧化物水溶液加入反应液和将酸加入其中的步骤交替重复两次或更多次的间隔时间内进行。
  • Novel compounds having antiinflamatory activity: process for their preparation and pharmaceutical compositions containing them
    申请人:DR. REDDY'S LABORATORIES LTD.
    公开号:US20020032230A1
    公开(公告)日:2002-03-14
    The present invention relates to novel heterocyclic compounds of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their regioisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. 1
    本发明涉及一种新型杂环化合物,其一般式为(I),其衍生物,类似物,互变异构体,立体异构体,区域异构体,多晶形态,药学上可接受的盐,药学上可接受的溶剂化合物和药学上可接受的含有它们的组合物。
  • [EN] PYRAZOLES HAVING ANTIINFLAMMATORY ACTIVITY<br/>[FR] PYRAZOLES PRESENTANT UNE ACTIVITE ANTI-INFLAMMATOIRE
    申请人:REDDY RESEARCH FOUNDATION
    公开号:WO2000066562A1
    公开(公告)日:2000-11-09
    The present invention relates to novel antiinflammatory compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their regioisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel heterocyclic compounds of general the formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their regioisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them.
    本发明涉及新型抗炎化合物、它们的衍生物、类似物、互变异构体、立体异构体、区域异构体、多晶形态、药学上可接受的盐、药学上可接受的溶剂化合物以及含有它们的药学上可接受的组合物。更具体地说,本发明涉及一般式(I)的新型杂环化合物、它们的衍生物、类似物、互变异构体、立体异构体、区域异构体、多晶形态、药学上可接受的盐、药学上可接受的溶剂化合物以及含有它们的药学上可接受的组合物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐